The inclusion of the hospital exemption for advanced therapies in the new pharmaceutical regulation does not satisfy health organizations and industry amidst accessibility concerns.
ADVERTISEMENTA European Commission proposal to tighten conditions in which Advanced Therapy Medicinal Products (ATMPs) may benefit from a special exemption for use in hospitals has divided health stakeholders with concerns about the lack of EU-wide…
